BNT165b1

BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
BioSpace
Fri, 12/23/22 - 10:37 am
BioNTech
clinical trials
malaria
MRNA
vaccines
BNT165b1